serum lipoproteins were modulated by the drug with a decrease in cholesterol and triglycerides in the chylomicron , very low-density lipoproteins ( vldl ) , and low-density lipoproteins ( ldl ) and an increase in high-density lipoprotein ( hdl ) cholesterol .
C0008377
cholesterol
C0023822
high-density lipoprotein